Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-15-071997
Filing Date
2015-12-21
Accepted
2015-12-21 17:22:39
Documents
3
Group Members
BENJAMIN H. SNEDEKERDAVID BUCHENDR. JOHN H. LEAMANDR. TODD JOHNSONJAMES P. AHERNMATTHEW D. EITNERTIMOTHY S. CALLAHAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v426796_sc13da.htm SC 13D/A 125393
2 EXHIBIT 99.10 v426796_ex99-10.htm EX-99.10 3036
3 EXHIBIT 99.11 v426796_ex99-11.htm EX-99.11 8659
  Complete submission text file 0001144204-15-071997.txt   139182
Mailing Address 546 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10036
Business Address 41 DOVER STREET LONDON A1 W1S 4NS 212-953-4952
LAIDLAW & COMPANY (UK) LTD. (Filed by) CIK: 0001146350 (see all company filings)

State of Incorp.: XX | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88207 | Film No.: 151300227
SIC: 2834 Pharmaceutical Preparations